Clinical studies investigating the use of leuprorelin in Asian women with endometriosis: a review

References

• Abbott Laboratories. 2012. Lupron depot (leuprolide acetate) Product Information. Available from: https://www.fda.gov/drugs/informationondrugs/
   Google Scholar
• Aznaurova YB, Zhumataev MB, Roberts TK, Aliper AM, Zhavoronkov AA. 2014. Molecular aspects of development and regulation of endometriosis. Reproductive Biology and Endocrinology 12:50.
   PubMed Web of Science ®Google Scholar
• Casper RF. 2017a. Introduction: a focus on the medical management of endometriosis. Fertility and Sterility 107:521–522.
   PubMed Web of Science ®Google Scholar
• Casper RF. 2017b. Progestin-only pills may be a better first-line treatment for endometriosis than combined estrogen-progestin contraceptive pills. Fertility and sterility 107:533–536.
   Google Scholar
• Cheung TK, Lo KW, Lam CW, Lau W, Lam PK. 2000. A crossover study of triptorelin and leuprorelin acetate. Fertility and Sterility 74:299–305.
   PubMed Web of Science ®Google Scholar
• Crosignani PG, Luciano A, Ray A, Bergqvist A. 2006. Subcutaneous depot medroxyprogesterone acetate versus leuprolide acetate in the treatment of endometriosis-associated pain. Hum Reproduction 21:248–256.
   PubMed Web of Science ®Google Scholar
• Crosignani P, Olive D, Bergqvist A, Luciano A. 2006. Advances in the management of endometriosis: an update for clinicians. Human Reproduction Update 12:179–189.
   PubMed Web of Science ®Google Scholar
• Dunselman GA, Vermeulen N, Becker C, Calhaz-Jorge C, D'hooghe T, De Bie B, et al. 2014. Eshre guideline: management of women with endometriosis. Human Reproductio 29:400–412.
   PubMed Web of Science ®Google Scholar
• Fedele L, Parazzini F, Radici E, Bocciolone L, Bianchi S, Bianchi C, et al. 1992. Buserelin acetate versus expectant management in the treatment of infertility associated with minimal or mild endometriosis: a randomized clinical trial. American Journal of Obstetrics and Gynecology 166:1345–1350.
   PubMed Web of Science ®Google Scholar
• Guo SW. 2014. An overview of the current status of clinical trials on endometriosis: issues and concerns. Fertility and Sterility 101:183–190.e4.
   PubMed Web of Science ®Google Scholar
• Hayashi A, Tanabe A, Kawabe S, Hayashi M, Yuguchi H, Yamashita Y, et al. 2012. Dienogest increases the progesterone receptor isoform b/a ratio in patients with ovarian endometriosis. Journal of Ovarian Research 5:31.
   PubMed Web of Science ®Google Scholar
• Irahara M, Uemura H, Yasui T, Kinoshita H, Yamada M, Tezuka M, et al. 2001. Efficacy of every-other-day administration of conjugated equine estrogen and medroxyprogesterone acetate on gonadotropin-releasing hormone agonists treatment in women with endometriosis. Gynecologic and Obstetric Investigation 52:217–222.
   PubMed Web of Science ®Google Scholar
• Jeng CJ, Chuang L, Shen J. 2014. A comparison of progestogens or oral contraceptives and gonadotropin-releasing hormone agonists for the treatment of endometriosis: a systematic review. Expert Opinion on Pharmacotherapy 15:767–773.
   PubMed Web of Science ®Google Scholar
• Khine YM, Taniguchi F, Harada T. 2016. Clinical management of endometriosis-associated infertility. Reproductive Medicine and Biology 15:217–225.
   PubMedGoogle Scholar
• Kitawaki J, Kusuki I, Yamanaka K, Suganuma I. 2011. Maintenance therapy with dienogest following gonadotropin-releasing hormone agonist treatment for endometriosis-associated pelvic pain. European Journal of Obstetrics, Gynecology, and Reproductive Biology 157:212–216.
   PubMed Web of Science ®Google Scholar
• Kvaskoff M, Mu F, Terry KL, Harris HR, Poole EM, Farland L, et al. 2015. Endometriosis: a high-risk population for major chronic diseases? Human Reproduction Update 21:500–516.
   PubMed Web of Science ®Google Scholar
• Lagana AS, La Rosa VL, Rapisarda AMC, Valenti G, Sapia F, Chiofalo B, et al. 2017. Anxiety and depression in patients with endometriosis: impact and management challenges. International Journal of Women's Health 9:323–330.
   PubMed Web of Science ®Google Scholar
• Mori H, Taketani Y, Uemura T, Miyake A, Tango T. 1999. Rates of endometriosis recurrence and pregnancy 1 year after treatment with intranasal buserelin acetate (suprecur) (a prospective study). The Journal of Obstetrics and Gynaecology Research 25:153–164.
   PubMedGoogle Scholar
• Nnoaham KE, Hummelshoj L, Webster P, d’Hooghe T, de Cicco Nardone F, de Cicco Nardone C, et al. 2011. Impact of endometriosis on quality of life and work productivity: a multicenter study across ten countries. Fertility and Sterility 96:366–373.e8.
   PubMed Web of Science ®Google Scholar
• Ozkan S, Murk W, Arici A. 2008. Endometriosis and infertility: epidemiology and evidence-based treatments. Annals of the New York Academy of Sciences 1127:92–100.
   PubMed Web of Science ®Google Scholar
• Regidor PA, Regidor M, Kato K, Bier UW, Buhler K, Schindler AE. 1997. Long-term follow-up on the treatment of endometriosis with the gnrh-agonist buserelinacetate. Long-term follow-up data (up to 98 months) of 42 patients with endometriosis who were treated with gnrh-agonist buserelinacetate (suprecur), were evaluated in respect of recurrence of pain symptoms and pregnancy outcome. European Journal of Obstetrics, Gynecology, and Reproductive Biology 73:153–160.
   PubMed Web of Science ®Google Scholar
• Simpson PD, Mclaren JS, Rymer J, Morris EP. 2015. Minimising menopausal side effects whilst treating endometriosis and fibroids. Post Reproductive Health 21:16–23.
   PubMedGoogle Scholar
• Takeuchi H, Kobori H, Kikuchi I, Sato Y, Mitsuhashi N. 2000. A prospective randomized study comparing endocrinological and clinical effects of two types of Gnrh agonists in cases of uterine leiomyomas or endometriosis. The Journal of Obstetrics and Gynaecology Research 26:325–331.
   PubMedGoogle Scholar
• Waller KG, Shaw RW. 1993. Gonadotropin-releasing hormone analogues for the treatment of endometriosis: Long-term follow-up. Fertility and Sterility 59:511–515.
   PubMed Web of Science ®Google Scholar
• Yamamoto A, Johnstone EB, Bloom MS, Huddleston HG, Fujimoto VY. 2017. A higher prevalence of endometriosis among asian women does not contribute to poorer ivf outcomes. Journal of Assisted Reproduction and Genetics 34:765–774.
   PubMed Web of Science ®Google Scholar
• Yamanaka A, Hada T, Matsumoto T, Kanno K, Shirane A, Yanai S, et al. 2017. Effect of dienogest on pain and ovarian endometrioma occurrence after laparoscopic resection of uterosacral ligaments with deep infiltrating endometriosis. European Journal of Obstetrics, Gynecology, and Reproductive Biology 216:51–55.
   PubMed Web of Science ®Google Scholar
• Zhou LM, Zheng J, Sun YT, Zhao YY, Xia AL. 2013. [Study on leuprorelin acetate in treatment of uterine adenomyosis with infertility]. Zhonghua Fu Chan Ke Za Zhi 48:334–337.
   PubMedGoogle Scholar
• Zhu X, Wong F, Bensoussan A, Lo SK, Zhou C, Yu J. 2010. Are there any cross-ethnic differences in menstrual profiles? A pilot comparative study on Australian and Chinese women with primary dysmenorrhea. The Journal of Obstetrics and Gynaecology Research 36:1093–1101.
   PubMed Web of Science ®Google Scholar